Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 1Q Financial Report: Bristol-Myers Squibb | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

1Q Financial Report: Bristol-Myers Squibb

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

1Q Revenues: $4.7 billion (+3%)

1Q Earnings: $714 million (+33%)

Comments: Plavix, Avapro/Avalide, Abilify, Reyataz and Erbitux all delivered double-digit sales increases. The company launched RA biologic Orencia and received additional approval for Erbitux during 1Q2006. U.S. pharmaceutical revenues rose 17% to $2.1 billion, while international pharma sales dropped 10%, including a 5% drop due to exchange rates, to $1.6 billion.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters